Hepatic encephalopathy

Emerg Med Clin North Am. 2009 Aug;27(3):401-14. doi: 10.1016/j.emc.2009.04.005.

Abstract

Hepatic encephalopathy is characterized by a wide spectrum of neuropsychiatric abnormalities and motor disturbances in patients with advanced liver disease. It is estimated to occur in 30% to 45% of patients with liver cirrhosis and in 10% to 50% of patients with transjugular intrahepatic portosystemic shunts. It can be seen in cancer patients due to multiple factors. Early diagnosis and treatment are important but can be challenging, especially in mild forms with subtle findings. This article reviews the pathogenesis, diagnostic criteria, grading, and management of hepatic encephalopathy.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / adverse effects
  • Brain Edema / diagnosis
  • Brain Edema / etiology
  • Brain Edema / therapy
  • Hepatic Encephalopathy / classification
  • Hepatic Encephalopathy / complications
  • Hepatic Encephalopathy / diagnosis*
  • Hepatic Encephalopathy / therapy*
  • Humans
  • Intracranial Hypertension / diagnosis
  • Intracranial Hypertension / etiology
  • Intracranial Hypertension / therapy
  • Liver Failure, Acute / complications
  • Neoplasm Invasiveness
  • Neoplasms / complications
  • Neoplasms / pathology
  • Prognosis
  • Severity of Illness Index

Substances

  • Antineoplastic Agents